Agilon Health (NYSE:AGL) Hits New 1-Year High – Should You Buy?

Agilon Health, Inc. (NYSE:AGL) shares hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $90.48 and last traded at $86.4310, with a volume of 399530 shares traded. The stock had previously closed at $81.73.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on AGL shares. Robert W. Baird increased their price target on shares of Agilon Health from $20.00 to $35.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Deutsche Bank Aktiengesellschaft raised shares of Agilon Health from a “hold” rating to a “buy” rating and increased their price target for the stock from $33.00 to $49.00 in a research report on Thursday, May 7th. Barclays reduced their price target on shares of Agilon Health from $25.00 to $12.50 and set an “underweight” rating on the stock in a research report on Friday, February 27th. Benchmark increased their price target on shares of Agilon Health to $13.00 and gave the stock a “buy” rating in a research report on Thursday, April 2nd. Finally, Weiss Ratings raised shares of Agilon Health from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, May 12th. Five analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, Agilon Health has an average rating of “Hold” and a consensus target price of $45.05.

Agilon Health Trading Up 5.8%

The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04. The business’s 50 day moving average is $26.74 and its 200 day moving average is $20.61. The stock has a market cap of $1.44 billion, a price-to-earnings ratio of -4.01 and a beta of 2.29.

Agilon Health (NYSE:AGL) last issued its earnings results on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.76. The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.38 billion. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. As a group, equities analysts expect that Agilon Health, Inc. will post -4.17 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Agilon Health

Hedge funds have recently added to or reduced their stakes in the stock. Wealthcare Advisory Partners LLC purchased a new position in Agilon Health in the third quarter valued at approximately $26,000. LPL Financial LLC increased its stake in Agilon Health by 213.4% in the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after purchasing an additional 30,000 shares during the last quarter. Krilogy Financial LLC purchased a new position in Agilon Health in the fourth quarter valued at approximately $34,000. CIBC Bancorp USA Inc. purchased a new position in Agilon Health in the third quarter valued at approximately $34,000. Finally, Merit Financial Group LLC purchased a new position in Agilon Health in the fourth quarter valued at approximately $35,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.